Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy

Background. The main factors that increase the risk of cardiovascular accidents and mortality among patients with COVID-19 include hyperglycemia, arterial hypertension and dyslipidemia. Therefore, all patients with COVID-19 and metabolic syndrome should receive antihypertensive (AHT), hypolipidemic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tatiana Yu. Demidova, Kristina G. Lobanova, Sergey N. Perekhodov, Michail B. Antsiferov, Olga S. Oynotkinova
Formato: article
Lenguaje:RU
Publicado: "Consilium Medicum" Publishing house 2021
Materias:
R
Acceso en línea:https://doaj.org/article/a324d85d2b694f45bd8dce55506f770a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!